Elly Ryu - 01 Jun 2022 Form 4 Insider Report for Sesen Bio, Inc. (CARM)

Role
Principal Accounting Officer
Signature
/s/ Mark R. Sullivan, as attorney-in-fact
Issuer symbol
CARM
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Jun 2022, 19:22:36 UTC
Previous filing
23 Feb 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Employee Stock Option (Right to Buy) Award $0 +95,500 $0.000000 95,500 01 Jun 2022 Common Stock 95,500 $0.5834 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 1, 2022, the reporting person was awarded options to purchase 95,500 shares of the common stock of Sesen Bio, Inc. (the "Company"), which options vest 6.25% every three months over four years provided the reporting person is employed by the Company at each such vest date.